An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome

Maria L. Taylor(Boston Children's Hospital), Lauren A. Henderson(Boston Children's Hospital), Maria Laura Alfieri(University of Naples Federico II), Mark Gorman(Boston Children's Hospital), Siobhan Case(Yale University), Ezra M. Cohen(Boston Children's Hospital), Jenny Chan Yeun(Boston Children's Hospital), Leslie Benson(Boston Children's Hospital), Olha Halyabar(Boston Children's Hospital), Jordan E. Roberts, Barbara Degar(Dana-Farber Cancer Institute), Jeffrey Lo(Boston Children's Hospital), Mindy S. Lo(Boston Children's Hospital), Melissa M. Hazen(Boston Children's Hospital), Craig D. Platt(Boston Children's Hospital), Joseph Han(Icahn School of Medicine at Mount Sinai), Mia T. Chandler(Boston Children's Hospital), Kacie J. Hoyt(Boston Children's Hospital), Damilola M. Shobiye(Boston Children's Hospital), Esra Meidan(Boston Children's Hospital), Gregory P. Priebe(Brigham and Women's Hospital), Margaret H. Chang(Boston Children's Hospital), Peter A. Nigrović(Brigham and Women's Hospital), Megan Day‐Lewis(Boston Children's Hospital), Joyce C. Chang(Boston Children's Hospital), Pui Y. Lee(Boston Children's Hospital), Erin Janssen(Boston Children's Hospital), Fatma Dedeoğlu(Boston Children's Hospital), Jonathan S. Hausmann(Beth Israel Deaconess Medical Center), Robert P. Sundel(Boston Children's Hospital), Mary Beth F. Son(Boston Children's Hospital)
The Journal of Rheumatology
July 15, 2022
Cited by 17


Related Papers